Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy-Reference-Cited by-同舟云学术

Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy

Published:2009-04 Issue:4 Volume:17 Page:593-599
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Chadderton Naomi,Millington-Ward Sophia,Palfi Arpad,O'Reilly Mary,Tuohy Gearóid,Humphries Marian M,Li Tiansen,Humphries Peter,Kenna Paul F,Farrar G Jane

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. Effect of gene therapy on visual function in Leber's congenital amaurosis;Bainbridge;N Engl J Med,2008

2. Safety and efficacy of gene transfer for Leber's congenital amaurosis;Maguire;N Engl J Med,2008

3. Phase I trial of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results;Hauswirth;Hum Gene Ther,2008

4. Caspase-dependent apoptosis in light-induced retinal degeneration;Perche;Invest Ophthalmol Vis Sci,2007

5. In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration;Buch;Mol Ther,2006

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-cell interaction in the pathogenesis of inherited retinal diseases;Frontiers in Cell and Developmental Biology;2024-03-04

2. Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice;Molecular Therapy - Nucleic Acids;2023-09

3. Gene augmentation for autosomal dominant retinitis pigmentosa using rhodopsin genomic loci nanoparticles in the P23H+/− knock-in murine model;Gene Therapy;2023-03-20

4. Application of Convergent Science and Technology toward Ocular Disease Treatment;Pharmaceuticals;2023-03-16

5. Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development;Pharmaceutics;2023-02-17